EXLS (ExlService Holdings, Inc.) Stock Analysis - News

ExlService Holdings, Inc. (EXLS) is a publicly traded Technology sector company. As of May 21, 2026, EXLS trades at $29.43 with a market cap of $4.43B and a P/E ratio of 23.95. EXLS moved +1.55% today. Year to date, EXLS is -29.95%; over the trailing twelve months it is -36.55%. Its 52-week range spans $26.82 to $52.43. Analyst consensus is strong buy with an average price target of $41.14. Rallies surfaces EXLS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What changed in EXLS news today?

EXL Named Leader in 2026 Everest Healthcare Payer AI Operations Assessment: EXL was named a Leader in the Everest Group Healthcare Payer Intelligent Operations PEAK Matrix 2026 assessment, evaluated across 33 providers on next-generation AI-enabled back-office capabilities. Its CareRadius platform’s analytics, predictive modeling and automation drove strong double-digit growth in EXL’s health and life sciences segment.

EXLS Key Metrics

Key financial metrics for EXLS
MetricValue
Price$29.43
Market Cap$4.43B
P/E Ratio23.95
EPS$1.22
Dividend Yield0.00%
52-Week High$52.43
52-Week Low$26.82
Volume0
Avg Volume0
Revenue (TTM)$1.84B
Net Income$198.30M
Gross Margin37.59%

Latest EXLS News

Recent EXLS Insider Trades

  • AYYAPPAN AJAY sold 1.68K (~$51.02K) on Mar 2, 2026.
  • AYYAPPAN AJAY sold 1.20K (~$35.66K) on Feb 23, 2026.
  • AYYAPPAN AJAY sold 1.23K (~$37.17K) on Feb 18, 2026.

EXLS Analyst Consensus

8 analysts cover EXLS: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $41.14.

Common questions about EXLS

What changed in EXLS news today?
EXL Named Leader in 2026 Everest Healthcare Payer AI Operations Assessment: EXL was named a Leader in the Everest Group Healthcare Payer Intelligent Operations PEAK Matrix 2026 assessment, evaluated across 33 providers on next-generation AI-enabled back-office capabilities. Its CareRadius platform’s analytics, predictive modeling and automation drove strong double-digit growth in EXL’s health and life sciences segment.
Does Rallies summarize EXLS news?
Yes. Rallies summarizes EXLS news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is EXLS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EXLS. It does not provide personalized investment advice.
EXLS

EXLS